Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | Niemann-Pick disease, type C1 | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | RAB9A, member RAS oncogene family | Starlite/ChEMBL | No references |
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Homo sapiens | breast cancer 1, early onset | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | ras-related protein Rab-5B | RAB9A, member RAS oncogene family | 201 aa | 165 aa | 30.9 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | RNA, U transporter 1 | 0.0099 | 0.0472 | 0.0472 |
Leishmania major | hypothetical protein, conserved | 0.0402 | 0.3456 | 0.3209 |
Mycobacterium ulcerans | glutaminase | 0.033 | 0.2746 | 0.5 |
Brugia malayi | glutaminase DH11.1 | 0.033 | 0.2746 | 0.2746 |
Echinococcus granulosus | tm gpcr rhodopsin | 0.0507 | 0.4486 | 1 |
Echinococcus granulosus | expressed conserved protein | 0.0112 | 0.0597 | 0.1331 |
Echinococcus multilocularis | snurportin 1 | 0.0372 | 0.3156 | 0.3455 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1512 | 0.479 |
Echinococcus multilocularis | lamin b receptor | 0.0088 | 0.0364 | 0.0399 |
Echinococcus granulosus | geminin | 0.0205 | 0.1512 | 0.337 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.0071 | 0.0225 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0119 | 0.0668 | 0.0731 |
Trypanosoma cruzi | Emopamil binding protein, putative | 0.0402 | 0.3456 | 0.3209 |
Echinococcus multilocularis | geminin | 0.0205 | 0.1512 | 0.1655 |
Loa Loa (eye worm) | hypothetical protein | 0.0119 | 0.0668 | 0.0668 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.2308 | 0.5145 |
Trypanosoma cruzi | lanosterol synthase, putative | 0.0142 | 0.0897 | 0.0553 |
Schistosoma mansoni | hypothetical protein | 0.0372 | 0.3156 | 1 |
Mycobacterium tuberculosis | Halimadienyl diphosphate synthase | 0.0079 | 0.0273 | 0.5 |
Echinococcus granulosus | snurportin 1 | 0.0372 | 0.3156 | 0.7035 |
Trypanosoma cruzi | 3-Beta-hydroxysteroid-delta(8), delta(7)-isomerase, putative | 0.0402 | 0.3456 | 0.3209 |
Brugia malayi | hypothetical protein | 0.0286 | 0.2308 | 0.2308 |
Leishmania major | lanosterol synthase, putative | 0.0123 | 0.0706 | 0.0355 |
Entamoeba histolytica | Niemann-Pick C1 protein, putative | 0.0119 | 0.0668 | 0.5 |
Brugia malayi | hypothetical protein | 0.015 | 0.0973 | 0.0973 |
Loa Loa (eye worm) | nucleolar RNA-associated protein alpha | 0.0372 | 0.3156 | 0.3156 |
Brugia malayi | Niemann-Pick C1 protein precursor | 0.0119 | 0.0668 | 0.0668 |
Trypanosoma cruzi | 3-Beta-hydroxysteroid-delta(8), delta(7)-isomerase, putative | 0.0402 | 0.3456 | 0.3209 |
Schistosoma mansoni | glutaminase | 0.033 | 0.2746 | 0.8702 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0119 | 0.0668 | 0.1489 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.017 | 0.117 | 0.2608 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0979 | 0.9134 | 1 |
Trichomonas vaginalis | glutaminase, putative | 0.033 | 0.2746 | 1 |
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.0121 | 0.0686 | 0.2174 |
Loa Loa (eye worm) | glutaminase 2 | 0.033 | 0.2746 | 0.2746 |
Trypanosoma brucei | lanosterol synthase | 0.0142 | 0.0897 | 0.0553 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.2308 | 0.2308 |
Loa Loa (eye worm) | hypothetical protein | 0.015 | 0.0973 | 0.0973 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.1067 | 1 | 1 |
Loa Loa (eye worm) | glutaminase | 0.033 | 0.2746 | 0.2746 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.017 | 0.117 | 0.1281 |
Echinococcus granulosus | lamin b receptor | 0.0088 | 0.0364 | 0.0812 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1512 | 0.479 |
Onchocerca volvulus | 0.015 | 0.0973 | 0.2664 | |
Loa Loa (eye worm) | hypothetical protein | 0.1067 | 1 | 1 |
Echinococcus multilocularis | protein dispatched 1 | 0.0058 | 0.0071 | 0.0078 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.0071 | 0.0071 |
Loa Loa (eye worm) | hypothetical protein | 0.0545 | 0.4866 | 0.4866 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.1067 | 1 | 1 |
Schistosoma mansoni | Lamin B receptor (ERG24) | 0.0088 | 0.0364 | 0.1154 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | 0.0507 | 0.4486 | 0.4911 |
Leishmania major | C-8 sterol isomerase-like protein | 0.1067 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 0.0113 | 0.0113 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.2308 | 0.2527 |
Trypanosoma cruzi | lanosterol synthase, putative | 0.0142 | 0.0897 | 0.0553 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.0071 | 0.0225 |
Onchocerca volvulus | 0.0402 | 0.3456 | 1 | |
Echinococcus multilocularis | expressed conserved protein | 0.0112 | 0.0597 | 0.0654 |
Trypanosoma brucei | Emopamil binding protein, putative | 0.0402 | 0.3456 | 0.3209 |
Leishmania major | 3-Beta-hydroxysteroid-delta(8), delta(7)-isomerase, putative | 0.0402 | 0.3456 | 0.3209 |
Trypanosoma cruzi | Emopamil binding protein, putative | 0.0402 | 0.3456 | 0.3209 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 15.868 um | PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Activators of 5'UTR Stem-Loop Driven Prion Protein mRNA Translation in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1829 (Project Summary), 1814 (Primary HTS)] | ChEMBL. | No reference |
Potency (functional) | 0.1158 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 3.1623 um | PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 4.4668 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 5.6234 um | PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 6.3096 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 16.3535 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143] | ChEMBL. | No reference |
Potency (functional) | 16.5113 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 26.8545 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | 29.081 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.